RAPT Therapeutics Inc (RAPT)
7.85
-0.10
(-1.26%)
USD |
NASDAQ |
Apr 22, 16:00
7.865
+0.02
(+0.19%)
After-Hours: 20:00
RAPT Therapeutics Market Cap: 273.16M for April 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 273.16M |
| April 19, 2024 | 276.64M |
| April 18, 2024 | 275.95M |
| April 17, 2024 | 279.77M |
| April 16, 2024 | 282.91M |
| April 15, 2024 | 297.17M |
| April 12, 2024 | 319.79M |
| April 11, 2024 | 326.40M |
| April 10, 2024 | 313.88M |
| April 09, 2024 | 293.69M |
| April 08, 2024 | 289.52M |
| April 05, 2024 | 274.90M |
| April 04, 2024 | 278.73M |
| April 03, 2024 | 290.91M |
| April 02, 2024 | 285.69M |
| April 01, 2024 | 294.04M |
| March 28, 2024 | 312.48M |
| March 27, 2024 | 310.74M |
| March 26, 2024 | 292.30M |
| March 25, 2024 | 287.78M |
| March 22, 2024 | 289.86M |
| March 21, 2024 | 296.13M |
| March 20, 2024 | 302.04M |
| March 19, 2024 | 300.65M |
| March 18, 2024 | 289.86M |
| Date | Value |
|---|---|
| March 15, 2024 | 294.74M |
| March 14, 2024 | 292.65M |
| March 13, 2024 | 298.56M |
| March 12, 2024 | 277.34M |
| March 11, 2024 | 281.86M |
| March 08, 2024 | 315.96M |
| March 07, 2024 | 322.92M |
| March 06, 2024 | 318.05M |
| March 05, 2024 | 302.04M |
| March 04, 2024 | 301.70M |
| March 01, 2024 | 308.90M |
| February 29, 2024 | 294.79M |
| February 28, 2024 | 297.89M |
| February 27, 2024 | 309.24M |
| February 26, 2024 | 324.03M |
| February 23, 2024 | 299.95M |
| February 22, 2024 | 317.84M |
| February 21, 2024 | 350.17M |
| February 20, 2024 | 236.32M |
| February 16, 2024 | 893.32M |
| February 15, 2024 | 878.53M |
| February 14, 2024 | 878.88M |
| February 13, 2024 | 859.61M |
| February 12, 2024 | 909.84M |
| February 09, 2024 | 900.55M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
236.32M
Minimum
Feb 20 2024
1.189B
Maximum
Jan 06 2022
661.48M
Average
639.87M
Median
Jan 20 2022
Market Cap Benchmarks
| Emergent BioSolutions Inc | 112.76M |
| Avinger Inc | 6.443M |
| Tonix Pharmaceuticals Holding Corp | 14.85M |
| Skye Bioscience Inc | 415.33M |
| Axsome Therapeutics Inc | 3.368B |
Market Cap Related Metrics
| PS Ratio | 92.63 |
| PEG Ratio | -0.5299 |
| Price to Book Value | 1.858 |
| Price | 7.85 |
| Earnings Yield | -38.85% |
| PEGY Ratio | -0.5299 |